Can COVID-19 Cause Pulmonary Hypertension?

COVID-19 emerged as a global health challenge, causing significant health disruptions. Pulmonary hypertension (PH) is a serious and progressive condition impacting the blood vessels within the lungs.

What is Pulmonary Hypertension?

Pulmonary hypertension (PH) is characterized by abnormally high blood pressure in the arteries that carry blood from the heart to the lungs. PH specifically affects the pulmonary circulation. When these pulmonary arteries narrow or stiffen, the heart’s right side must work harder to pump blood through the lungs, causing pressure to rise.

The World Health Organization (WHO) classifies PH into five groups based on underlying causes. Group 1, Pulmonary Arterial Hypertension (PAH), involves narrowing or stiffening of the small pulmonary arteries. Group 2 PH is the most common type and results from left-sided heart disease, where issues with the left heart’s pumping or valves cause blood to back up into the lungs.

Group 3 PH is linked to lung diseases or low oxygen levels, such as chronic obstructive pulmonary disease (COPD) or interstitial lung diseases. Group 4, chronic thromboembolic pulmonary hypertension (CTEPH), arises from unresolved blood clots in the pulmonary arteries that lead to scar tissue, obstructing blood flow. Group 5 includes PH with unclear or multiple causes, encompassing conditions like sickle cell disease. This sustained high pressure can eventually enlarge and weaken the right side of the heart, potentially leading to right-sided heart failure.

How COVID-19 Can Lead to Pulmonary Hypertension

COVID-19 infection can contribute to pulmonary hypertension through several complex biological mechanisms. The SARS-CoV-2 virus directly damages lung tissue and blood vessels, as evidenced by autopsy studies. This direct viral impact on the endothelial cells, which line blood vessels, can lead to widespread vascular dysfunction.

An exaggerated inflammatory response, often referred to as a “cytokine storm,” is another mechanism. This uncontrolled release of pro-inflammatory cytokines, like IL-6, contributes to lung damage and can promote a pro-coagulant environment in the vasculature. This severe inflammation can damage lung tissue and blood vessels.

COVID-19 also increases the risk of micro-clot formation (thrombosis) within the pulmonary arteries. Autopsy findings show widespread thrombosis and microangiopathy in the pulmonary vessels of COVID-19 patients. These tiny blood clots can impede blood flow and oxygen exchange. Persistent clots can lead to chronic thromboembolic pulmonary hypertension (CTEPH).

Long-term effects of lung scarring, or pulmonary fibrosis, following severe COVID-19 pneumonia can also contribute to Group 3 PH. This scarring thickens lung tissue, reducing its elasticity and impairing gas exchange, which can lead to increased pressure in the pulmonary arteries.

The virus’s interaction with the body’s renin-angiotensin system (RAS) via the ACE2 receptor is another proposed mechanism. SARS-CoV-2 binds to and internalizes the ACE2 receptor, which is expressed on lung and heart cells, leading to its downregulation. Since ACE2 normally counterbalances angiotensin II, its reduction can lead to an imbalance in the RAS, promoting vasoconstriction, inflammation, and fibrosis in the lungs.

Recognizing Symptoms and Diagnosis

Recognizing the symptoms of pulmonary hypertension, especially in individuals with a history of COVID-19, is important for early detection. Common symptoms include shortness of breath and fatigue. Other signs can include chest pain, lightheadedness or dizziness, a racing heartbeat, and swelling in the ankles or legs (edema). These symptoms can sometimes be mistaken for other lung or heart conditions, making early diagnosis challenging.

The diagnostic process for pulmonary hypertension begins with an initial suspicion based on symptoms and a physical examination. Blood tests and an electrocardiogram (ECG) are performed as part of the initial screening. A chest X-ray can also provide early indications of lung or heart changes.

The most common screening tool is an echocardiogram, which estimates pulmonary artery pressure and assesses the heart’s right ventricle. While an echocardiogram can suggest PH, a definitive diagnosis and clarification of the PH subtype require a right heart catheterization. This invasive procedure, considered the “gold standard,” involves inserting a thin catheter to directly measure pressures and assess blood flow.

Managing Pulmonary Hypertension After COVID-19

Managing pulmonary hypertension after a COVID-19 infection involves a comprehensive and individualized approach. Medications are prescribed to dilate blood vessels in the lungs, reduce pulmonary blood pressure, and prevent clots. These include vasodilators, which relax and open blood vessels, and anticoagulants (blood thinners) to prevent blood clot formation.

Supportive therapies play a role in managing symptoms and improving quality of life. Oxygen therapy is recommended for individuals with low oxygen levels, as reduced oxygen can worsen pulmonary hypertension. Diuretics are used to reduce fluid retention and swelling in the legs or abdomen, which can alleviate strain on the heart.

Lifestyle recommendations are an important part of managing PH. Maintaining a balanced diet with sodium restriction helps reduce fluid overload. Regular, supervised exercise programs can improve cardiovascular fitness without overstraining the right ventricle. Avoiding smoking is advised, as it can worsen PH progression. Individuals with PH may also be advised to avoid high altitudes due to lower oxygen levels.

Regular monitoring and follow-up with specialists, such as cardiologists and pulmonologists, are necessary to track disease progression and adjust treatment plans. These appointments include physical exams, diagnostic tests like echocardiograms, and blood work to assess therapy effectiveness. Treatment plans are tailored to the specific type and severity of PH, and continuous communication with the healthcare team helps ensure optimal management.

Can Strep Throat Hurt Your Ears and Cause Ear Pain?

Bite Antibody: How It Works for Rabies and Venom

Can Physical Therapy Help With Osteoarthritis?